Ecaterina Ileana Dumbrava, MD

home / authors / ecaterina-ileana-dumbrava-md

Ecaterina Ileana Dumbrava, MD, is an assistant professor in the Department of Investigational Cancer Therapeutics of the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center.

Articles

Rationale for Adding BDC-1001 to Immune Checkpoint Inhibitor Therapy in HER2+ Breast Cancer

Rationale for Adding BDC-1001 to Immune Checkpoint Inhibitor Therapy in HER2+ Breast Cancer

February 10th 2021

Ecaterina Ileana Dumbrava, MD, discusses the rationale for combing BDC-1001, a HER2-targeting TLR7/8 immune-stimulating antibody conjugate with an immune checkpoint inhibitor.